• home
  • MOA of PCSK9i
  • PCSK9i Therapies
  • PCSK9i CVOTs
  • ACC/AHA Guidelines
  • IfPA Report Card
  • NLA Survey Results
  • PCSK9i Pricing Update
  • Improving Patient Access
  • Summary

NLA Survey Results

Keys to Successful Navigation of PCSK9i Approval Process

Click to hear faculty discussion on keys to successful navigation of PSCK9i approval
  • Use of specialty pharmacy
  • Persistence
  • Appeal
  • Documentation of adjunctive therapy
  • Current labs
  • Adequate documentation
  • Indication documentation
  • Documentation of statin use
Glossary
(Glossary)
ASCVD
atherosclerotic cardiovascular disease
CVD
cardiovascular disease
D
day
FH
familial hypercholesterolemia
HeFH
heterozygous FH
HoFH
homozygous FH
MI
myocardial infarction
PAD
peripheral artery disease
Q2W
every 2 weeks
QM
monthly
UA
unstable angina
W
week
References
Cohen JD, et al. J Clin Lipidol. 2017;11:891-900.